title: A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement.
abstract: BACKGROUND
  Lower urinary tract symptoms in men, over age of 50 years is suggestive of benign prostatic enlargement (BPE). Different alpha-blockers have been evaluated for the treatment of benign prostatic hyperplasia for over last 30 years. This study was conducted in a tertiary care institution during the period of year between June 2011 and August 2013 to compare the effect of naftopidil and tamsulosin in reducing the obstructive and irritable symptoms of BPE.
  
  
  METHODS
  A prospective randomized comparative study was carried on 60 patients of BPE by assigning half of them to treatment with tamsulosin and rest with naftopidil. Pre- and post-treatment uroflowmetry (UFM), post-void residue (PVR), International Prostate Symptoms Score (IPSS), were obtained at 15 and 30 days after starting treatment.
  
  
  RESULTS
  The age of patients ranged from 51 to 78. At base line there was no statistical difference between UFM parameter, PVR and IPSS in the two groups. UFM and PVR showed significantly better response at both intervals with naftopidil. Comparison of IPSS showed better improvement in Group A both at 15 and 30 days. It was seen that the obstructive symptoms showed a significantly better response with tamsulosin and symptoms of irritability was seen better response with naftopidil.
  
  
  CONCLUSIONS
  It was seen that during the period of follow-up of 30 days naftopidil had a better effect on UFM, PVR, IPSS compared with tamsulosin. In general, obstructive symptoms showed better improvement in tamsulosin and irritative symptoms showed better improvement in naftopidil.
authors: Department of Urology, MGMC and RI, Puducherry, India.
authors: Chenthil
authors: C
authors: Perumal
authors: Department of Urology, MGMC and RI, Puducherry, India.
authors: Puskar Shyam
authors: PS
authors: Chowdhury
authors: Department of Urology, MGMC and RI, Puducherry, India.
authors: N
authors: N
authors: Ananthakrishnan
authors: Department of Urology, MGMC and RI, Puducherry, India.
authors: Prasant
authors: P
authors: Nayak
authors: Department of Urology, MGMC and RI, Puducherry, India.
authors: Srinivasan
authors: S
authors: Gurumurthy
keywords: Alpha-1D blockers; benign prostatic hyperplasia; lower urinary tract symptoms; naftopidil
references: Brain Res Mol Brain Res. 1999 Jan 8;63(2):254-61
references: 9878769
references: Int J Urol. 1996 Jul;3(4):267-73
references: 8844281
references: J Urol. 2002 Mar;167(3):1513-21
references: 11832780
references: Scand J Urol Nephrol. 2010 Feb;44(1):38-45
references: 20095868
references: Pharmacol Rev. 1995 Jun;47(2):267-70
references: 7568329
references: Eur Urol. 2001;40 Suppl 4:5-11
references: 11786674
references: J Urol. 2005 Feb;173(2):657-61
references: 15643283
references: Int J Urol. 2003 Nov;10(11):587-94
references: 14633083
references: BJU Int. 2006 Apr;97(4):747-51, discussion 751
references: 16536766
references: Rev Urol. 2006;8 Suppl 4:S3-9
references: 17215999
references: Br J Urol. 1976 Aug;48(4):255-63
references: 61054
references: Nat Clin Pract Urol. 2007 Jul;4(7):368-78
references: 17615548
references: Ther Clin Risk Manag. 2011;7:227-38
references: 21753885
references: Int J Urol. 2008 Dec;15(12):1049-54
references: 19120513
references: Neurosci Lett. 2002 Aug 2;328(1):74-6
references: 12123863
references: J Urol. 2004 Mar;171(3):1029-35
references: 14767264
references: J Urol. 2006 Aug;176(2):665-71
references: 16813918
references: Neurourol Urodyn. 2006;25(5):461-7
references: 16673377
references: J Urol. 2003 Aug;170(2 Pt 1):530-47
references: 12853821